Characterization of Key Epigenetic Targets in Hepatic Fibrosis and Hepatocellular Carcinoma Development. Generation of New Antifibrotic and Antitumoral Drugs.

Norman Wolmark

NRG Oncology Network Group Operations Center

Liver and intrahepatic bile ducts

Radiation Oncology Surgery / Surgical oncology

Jian-Min Yuan

Prospective Studies of Cancer Etiology and Prevention in Shanghai and Singapore

Liver and intrahepatic bile ducts

Pathology

Charles D Blanke

SWOG Network Group Operations Center of the NCTN

Liver and intrahepatic bile ducts

Snorri Thorgeirsson

Genomic Classification of Human Liver Cancer

Liver and intrahepatic bile ducts

Pathology

Naveenta Kumar

The role of LLT1 in the liver and in hepatocellular carcinoma.

Liver and intrahepatic bile ducts

John Tavis

N-hydroxyisoquinolinediones as HCC Preventatives

Liver and intrahepatic bile ducts

Pathology

Paul J Brindley

Biomarkers of Opisthorchis Viverrini-Induced Cholangiocarcinoma

Liver and intrahepatic bile ducts

Pathology

Sylvia Silver

The East Coast Aids and Cancer Specimen Resource

Trachea, bronchus and lung Non-Hodgkin lymphoma Liver and intrahepatic bile ducts Cervix uteri

Tim Greten

Immune Suppressor Mechanism Analysis in Patients with Hepatocellular Carcinoma

Liver and intrahepatic bile ducts

Pathology